Z-0676-2019 Class II Terminated
FDA device recall Z-0676-2019 was initiated by Tosoh Bioscience Inc on Nov 30, 2018 and is designated Class II. The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 1085 units.
Recall details
- Product Type
- Devices
- Report Date
- Jan 2, 2019
- Initiation Date
- Nov 30, 2018
- Termination Date
- Jan 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1085 units
Product description
ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Adrenocorticotropic hormone (ACTH) in human EDT A plasma. Measurements of ACTH are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency and the ectopic ACTH syndrome.
Distribution pattern
US Nationwide
Code information
all lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0676-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026